{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T22:58:46Z","timestamp":1790031526658,"version":"4.0.1"},"reference-count":120,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,6]],"date-time":"2022-01-06T00:00:00Z","timestamp":1641427200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL049244"],"award-info":[{"award-number":["R01HL049244"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL132525"],"award-info":[{"award-number":["R01HL132525"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32HL149637"],"award-info":[{"award-number":["T32HL149637"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Basic to Translational Science"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.jacbts.2021.12.010","type":"journal-article","created":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T16:34:15Z","timestamp":1648658055000},"page":"730-742","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Short-Chain Carbon Sources"],"prefix":"10.1016","volume":"7","author":[{"given":"Azariyas A.","family":"Challa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Douglas","family":"Lewandowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacbts.2021.12.010_bib1","first-page":"e38","article-title":"Heart disease and stroke statistics\u20142016 update: a report from the American Heart Association","volume":"133","author":"Mozaffarian","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2021.12.010_bib2","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1161\/CIRCRESAHA.119.313572","article-title":"Heart failure with preserved ejection fraction in perspective","volume":"124","author":"Pfeffer","year":"2019","journal-title":"Circ Res"},{"key":"10.1016\/j.jacbts.2021.12.010_bib3","doi-asserted-by":"crossref","first-page":"H1968","DOI":"10.1152\/ajpheart.00250.2002","article-title":"dl-3-Hydroxybutyrate administration prevents myocardial damage after coronary occlusion in rat hearts","volume":"283","author":"Zou","year":"2002","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jacbts.2021.12.010_bib4","doi-asserted-by":"crossref","first-page":"567","DOI":"10.33549\/physiolres.932338","article-title":"Short-term fasting reduces the extent of myocardial infarction and incidence of reperfusion arrhythmias in rats","volume":"61","author":"Snorek","year":"2012","journal-title":"Physiol Res"},{"key":"10.1016\/j.jacbts.2021.12.010_bib5","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.119.006573","article-title":"Chronically elevating circulating ketones can reduce cardiac inflammation and blunt the development of heart failure","volume":"13","author":"Byrne","year":"2020","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacbts.2021.12.010_bib6","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.124079","article-title":"The failing heart utilizes 3-hydroxybutyrate as a metabolic stress defense","volume":"4","author":"Horton","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.jacbts.2021.12.010_bib7","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.molmet.2014.07.010","article-title":"Cardiomyocyte-specific deficiency of ketone body metabolism promotes accelerated pathological remodeling","volume":"3","author":"Schugar","year":"2014","journal-title":"Mol Metab"},{"key":"10.1016\/j.jacbts.2021.12.010_bib8","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.120.007684","article-title":"Ketone ester treatment improves cardiac function and reduces pathologic remodeling in preclinical models of heart failure","volume":"14","author":"Yurista","year":"2021","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacbts.2021.12.010_bib9","doi-asserted-by":"crossref","unstructured":"Nikolic M, Zivkovic V, Jovic JJ, et\u00a0al. SGLT2 inhibitors: a focus on cardiac benefits and potential mechanisms. Heart Fail Rev. 2022;27(3):935-949. https:\/\/doi.org\/10.1007\/s10741-021-10079-9","DOI":"10.1007\/s10741-021-10079-9"},{"key":"10.1016\/j.jacbts.2021.12.010_bib10","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in patients with heart failure and reduced ejection fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacbts.2021.12.010_bib11","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1016\/j.jacc.2019.01.056","article-title":"Empagliflozin ameliorates adverse left ventricular remodeling in nondiabetic heart failure by enhancing myocardial energetics","volume":"73","author":"Santos-Gallego","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacbts.2021.12.010_bib12","first-page":"676","article-title":"Mediterranean diet for primary prevention of cardiovascular disease","volume":"369","author":"Estruch","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacbts.2021.12.010_bib13","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1161\/CIRCULATIONAHA.119.043081","article-title":"Deficiency of prebiotic fiber and insufficient signaling through gut metabolite-sensing receptors leads to cardiovascular disease","volume":"141","author":"Kaye","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2021.12.010_bib14","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1161\/CIRCULATIONAHA.116.024545","article-title":"High-fiber diet and acetate supplementation change the gut microbiota and prevent the development of hypertension and heart failure in hypertensive mice","volume":"135","author":"Marques","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2021.12.010_bib15","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1161\/CIRCULATIONAHA.118.036652","article-title":"Short-chain fatty acid propionate protects from hypertensive cardiovascular damage","volume":"139","author":"Bartolomaeus","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2021.12.010_bib16","doi-asserted-by":"crossref","first-page":"8139","DOI":"10.1111\/jcmm.14684","article-title":"Sodium butyrate attenuates angiotensin II-induced cardiac hypertrophy by inhibiting COX2\/PGE2 pathway via a HDAC5\/HDAC6-dependent mechanism","volume":"23","author":"Zhang","year":"2019","journal-title":"J\u00a0Cell Mol Med"},{"key":"10.1016\/j.jacbts.2021.12.010_bib17","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1139\/cjpp-2019-0531","article-title":"Butyrate improves cardiac function and sympathetic neural remodeling following myocardial infarction in rats","volume":"98","author":"Jiang","year":"2020","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.jacbts.2021.12.010_bib18","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1161\/CIRCULATIONAHA.118.035235","article-title":"Loss of gut microbiota alters immune system composition and cripples postinfarction cardiac repair","volume":"139","author":"Tang","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2021.12.010_bib19","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1002\/jcb.25902","article-title":"Sodium butyrate protects against high fat diet-induced cardiac dysfunction and metabolic disorders in type II diabetic mice","volume":"118","author":"Zhang","year":"2017","journal-title":"J\u00a0Cell Biochem"},{"key":"10.1016\/j.jacbts.2021.12.010_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12012-017-9406-2","article-title":"Sodium butyrate controls cardiac hypertrophy in experimental models of rats","volume":"18","author":"Patel","year":"2018","journal-title":"Cardiovasc Toxicol"},{"key":"10.1016\/j.jacbts.2021.12.010_bib21","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/ejhf.1439","article-title":"The novel butyrate derivative phenylalanine-butyramide protects from doxorubicin-induced cardiotoxicity","volume":"21","author":"Russo","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacbts.2021.12.010_bib22","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1161\/HYPERTENSIONAHA.118.11695","article-title":"Prebiotics, probiotics, and acetate supplementation prevent hypertension in a model of obstructive sleep apnea","volume":"72","author":"Ganesh","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.jacbts.2021.12.010_bib23","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/nature12726","article-title":"Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation","volume":"504","author":"Arpaia","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.jacbts.2021.12.010_bib24","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.numecd.2014.01.002","article-title":"Butyrate impairs atherogenesis by reducing plaque inflammation and vulnerability and decreasing NFkappaB activation","volume":"24","author":"Aguilar","year":"2014","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.jacbts.2021.12.010_bib25","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/s41598-017-18756-2","article-title":"Metagenomic and metabolomic analyses unveil dysbiosis of gut microbiota in chronic heart failure patients","volume":"8","author":"Cui","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jacbts.2021.12.010_bib26","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.jacc.2017.12.057","article-title":"Gut microbiota signature in heart failure defined from profiling of 2 independent cohorts","volume":"71","author":"Kummen","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacbts.2021.12.010_bib27","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/ehf2.12155","article-title":"Heart failure is associated with depletion of core intestinal microbiota","volume":"4","author":"Luedde","year":"2017","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.jacbts.2021.12.010_bib28","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1042\/CS20180087","article-title":"Imbalance of gut microbiome and intestinal epithelial barrier dysfunction in patients with high blood pressure","volume":"132","author":"Kim","year":"2018","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.jacbts.2021.12.010_bib29","doi-asserted-by":"crossref","first-page":"3708","DOI":"10.1016\/j.clnu.2021.04.007","article-title":"Short-chain fatty acids combined with intronic DNA methylation of HIF3A: potential predictors for diabetic cardiomyopathy","volume":"40","author":"Guo","year":"2021","journal-title":"Clin Nutr"},{"key":"10.1016\/j.jacbts.2021.12.010_bib30","doi-asserted-by":"crossref","first-page":"3508","DOI":"10.1021\/acs.jproteome.1c00147","article-title":"Development of an efficient and sensitive chemical derivatization-based LC-MS\/MS method for quantifying gut microbiota-derived metabolites in human plasma and its application in studying cardiovascular disease","volume":"20","author":"Liao","year":"2021","journal-title":"J\u00a0Proteome Res"},{"key":"10.1016\/j.jacbts.2021.12.010_bib31","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.cmet.2016.12.022","article-title":"Multi-dimensional roles of ketone bodies in fuel metabolism, signaling, and therapeutics","volume":"25","author":"Puchalska","year":"2017","journal-title":"Cell Metab"},{"key":"10.1016\/j.jacbts.2021.12.010_bib32","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3390\/nu12020339","article-title":"The relationship between circulating acetate and human insulin resistance before and after weight loss in the DiOGenes study","volume":"12","author":"Gonzalez Hernandez","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.jacbts.2021.12.010_bib33","doi-asserted-by":"crossref","first-page":"661493","DOI":"10.3389\/fimmu.2021.661493","article-title":"Serum short-chain fatty acids and associations with inflammation in newly diagnosed patients with multiple sclerosis and healthy controls","volume":"12","author":"Olsson","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jacbts.2021.12.010_bib34","doi-asserted-by":"crossref","first-page":"5244","DOI":"10.1038\/s41598-021-84881-8","article-title":"Associations of serum short-chain fatty acids with circulating immune cells and serum biomarkers in patients with multiple sclerosis","volume":"11","author":"Trend","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.jacbts.2021.12.010_bib35","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202100481R","article-title":"Endocrine disruption in Crohn\u2019s disease: bisphenol A enhances systemic inflammatory response in patients with gut barrier translocation of dysbiotic microbiota products","volume":"35","author":"Linares","year":"2021","journal-title":"FASEB J"},{"issue":"3","key":"10.1016\/j.jacbts.2021.12.010_bib36","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.201700670","article-title":"Gut microbiome-induced shift of acetate to butyrate positively manages dysbiosis in high fat diet","volume":"62","author":"Si","year":"2018","journal-title":"Mol Nutr Food Res"},{"key":"10.1016\/j.jacbts.2021.12.010_bib37","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.3390\/cells9092007","article-title":"Tributyrin attenuates metabolic and inflammatory changes associated with obesity through a GPR109A-dependent mechanism","volume":"9","author":"Sato","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.jacbts.2021.12.010_bib38","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s002800050922","article-title":"Plasma pharmacokinetics of butyrate after intravenous administration of sodium butyrate or oral administration of tributyrin or sodium butyrate to mice and rats","volume":"43","author":"Egorin","year":"1999","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.jacbts.2021.12.010_bib39","doi-asserted-by":"crossref","first-page":"25481","DOI":"10.1074\/jbc.M301403200","article-title":"Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation","volume":"278","author":"Le Poul","year":"2003","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jacbts.2021.12.010_bib40","doi-asserted-by":"crossref","first-page":"8162","DOI":"10.1016\/S0021-9258(18)92956-X","article-title":"Myocardial triglyceride turnover and contribution to energy substrate utilization in isolated working rat hearts","volume":"266","author":"Saddik","year":"1991","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jacbts.2021.12.010_bib41","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1161\/01.CIR.0000127959.28627.F8","article-title":"Effect of obesity and insulin resistance on myocardial substrate metabolism and efficiency in young women","volume":"109","author":"Peterson","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2021.12.010_bib42","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/j.jacc.2009.04.074","article-title":"Altered myocardial substrate metabolism and decreased diastolic function in nonischemic human diabetic cardiomyopathy: studies with cardiac positron emission tomography and magnetic resonance imaging","volume":"54","author":"Rijzewijk","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacbts.2021.12.010_bib43","doi-asserted-by":"crossref","first-page":"5341","DOI":"10.1210\/en.2005-0938","article-title":"Reduced cardiac efficiency and altered substrate metabolism precedes the onset of hyperglycemia and contractile dysfunction in two mouse models of insulin resistance and obesity","volume":"146","author":"Buchanan","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.jacbts.2021.12.010_bib44","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1161\/CIRCULATIONAHA.106.668665","article-title":"Recruitment of compensatory pathways to sustain oxidative flux with reduced carnitine palmitoyltransferase I activity characterizes inefficiency in energy metabolism in hypertrophied hearts","volume":"115","author":"Sorokina","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2021.12.010_bib45","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s11010-008-9711-y","article-title":"Compensated cardiac hypertrophy is characterised by a decline in palmitate oxidation","volume":"311","author":"Akki","year":"2008","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.jacbts.2021.12.010_bib46","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1161\/01.CIR.94.11.2837","article-title":"Fatty acid oxidation enzyme gene expression is downregulated in the failing heart","volume":"94","author":"Sack","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2021.12.010_bib47","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1126\/science.abc8861","article-title":"Comprehensive quantification of fuel use by the failing and nonfailing human heart","volume":"370","author":"Murashige","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.jacbts.2021.12.010_bib48","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1161\/CIRCRESAHA.112.274456","article-title":"Acute liver carnitine palmitoyltransferase I overexpression recapitulates reduced palmitate oxidation of cardiac hypertrophy","volume":"112","author":"Lewandowski","year":"2013","journal-title":"Circ Res"},{"key":"10.1016\/j.jacbts.2021.12.010_bib49","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.yjmcc.2006.06.004","article-title":"Overexpression of angiotensinogen in the myocardium induces downregulation of the fatty acid oxidation pathway","volume":"41","author":"Pellieux","year":"2006","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.jacbts.2021.12.010_bib50","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.cardiores.2005.02.004","article-title":"Carnitine palmitoyl transferase-I inhibition prevents ventricular remodeling and delays decompensation in pacing-induced heart failure","volume":"66","author":"Lionetti","year":"2005","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacbts.2021.12.010_bib51","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1042\/bj1720377","article-title":"Pyruvate and ketone-body transport across the mitochondrial membrane. Exchange properties, pH-dependence and mechanism of the carrier","volume":"172","author":"Halestrap","year":"1978","journal-title":"Biochem J"},{"key":"10.1016\/j.jacbts.2021.12.010_bib52","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1161\/hc0302.102594","article-title":"Mitochondrial preference for short chain fatty acid oxidation during coronary artery constriction","volume":"105","author":"Lewandowski","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2021.12.010_bib53","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1161\/CIRCULATIONAHA.115.017355","article-title":"The failing heart relies on ketone bodies as a fuel","volume":"133","author":"Aubert","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2021.12.010_bib54","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1161\/CIRCULATIONAHA.120.052671","article-title":"Short-chain fatty acids outpace ketone oxidation in the failing heart","volume":"143","author":"Carley","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2021.12.010_bib55","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1161\/CIRCULATIONAHA.115.017545","article-title":"Evidence for intramyocardial disruption of lipid metabolism and increased myocardial ketone utilization in advanced human heart failure","volume":"133","author":"Bedi","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2021.12.010_bib56","doi-asserted-by":"crossref","first-page":"10230","DOI":"10.1073\/pnas.0604392103","article-title":"Sirtuins deacetylate and activate mammalian acetyl-CoA synthetases","volume":"103","author":"Hallows","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jacbts.2021.12.010_bib57","doi-asserted-by":"crossref","first-page":"11420","DOI":"10.1074\/jbc.M008782200","article-title":"Acetyl-CoA synthetase 2, a mitochondrial matrix enzyme involved in the oxidation of acetate","volume":"276","author":"Fujino","year":"2001","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jacbts.2021.12.010_bib58","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1093\/cvr\/cvaa143","article-title":"Ketones can become the major fuel source for the heart but do not increase cardiac efficiency","volume":"117","author":"Ho","year":"2021","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacbts.2021.12.010_bib59","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1161\/CIRCULATIONAHA.118.036459","article-title":"Cardiovascular effects of treatment with the ketone body 3-hydroxybutyrate in chronic heart failure patients","volume":"139","author":"Nielsen","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2021.12.010_bib60","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1152\/physrev.1990.70.2.567","article-title":"Energy contributions of volatile fatty acids from the gastrointestinal tract in various species","volume":"70","author":"Bergman","year":"1990","journal-title":"Physiol Rev"},{"key":"10.1016\/j.jacbts.2021.12.010_bib61","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1126\/science.1227166","article-title":"Suppression of oxidative stress by beta-hydroxybutyrate, an endogenous histone deacetylase inhibitor","volume":"339","author":"Shimazu","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.jacbts.2021.12.010_bib62","doi-asserted-by":"crossref","first-page":"8030","DOI":"10.1073\/pnas.1016088108","article-title":"Short-chain fatty acids and ketones directly regulate sympathetic nervous system via G protein-coupled receptor 41 (GPR41)","volume":"108","author":"Kimura","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jacbts.2021.12.010_bib63","doi-asserted-by":"crossref","first-page":"26649","DOI":"10.1074\/jbc.C500213200","article-title":"(D)-beta-Hydroxybutyrate inhibits adipocyte lipolysis via the nicotinic acid receptor PUMA-G","volume":"280","author":"Taggart","year":"2005","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jacbts.2021.12.010_bib64","doi-asserted-by":"crossref","first-page":"23813","DOI":"10.1073\/pnas.1912573116","article-title":"Ketone body receptor GPR43 regulates lipid metabolism under ketogenic conditions","volume":"116","author":"Miyamoto","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jacbts.2021.12.010_bib65","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1152\/physiolgenomics.00089.2016","article-title":"Microbial short chain fatty acid metabolites lower blood pressure via endothelial G protein-coupled receptor 41","volume":"48","author":"Natarajan","year":"2016","journal-title":"Physiol Genomics"},{"key":"10.1016\/j.jacbts.2021.12.010_bib66","doi-asserted-by":"crossref","first-page":"11312","DOI":"10.1074\/jbc.M211609200","article-title":"The orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids","volume":"278","author":"Brown","year":"2003","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jacbts.2021.12.010_bib67","article-title":"Ketone body infusion with 3-hydroxybutyrate reduces myocardial glucose uptake and increases blood flow in humans: a positron emission tomography study","volume":"6","author":"Gormsen","year":"2017","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacbts.2021.12.010_bib68","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.149037","article-title":"Ketone body \u03b2-hydroxybutyrate is an autophagy-dependent vasodilator","volume":"6","author":"McCarthy","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.jacbts.2021.12.010_bib69","first-page":"H354","article-title":"NMR studies of beta-oxidation and short-chain fatty acid metabolism during recovery of reperfused hearts","volume":"261","author":"Lewandowski","year":"1991","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jacbts.2021.12.010_bib70","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1161\/HYPERTENSIONAHA.115.05315","article-title":"Gut dysbiosis is linked to hypertension","volume":"65","author":"Yang","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.jacbts.2021.12.010_bib71","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1161\/HYPERTENSIONAHA.115.06672","article-title":"Role of the gut microbiome in obstructive sleep apnea-induced hypertension","volume":"67","author":"Durgan","year":"2016","journal-title":"Hypertension"},{"key":"10.1016\/j.jacbts.2021.12.010_bib72","doi-asserted-by":"crossref","first-page":"691564","DOI":"10.3389\/fcvm.2021.691564","article-title":"Dietary interventions reduce traditional and novel cardiovascular risk markers by altering the gut microbiome and their metabolites","volume":"8","author":"Vijay","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.jacbts.2021.12.010_bib73","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1161\/HYPERTENSIONAHA.120.14800","article-title":"Modest sodium reduction increases circulating short-chain fatty acids in untreated hypertensives: a randomized, double-blind, placebo-controlled trial","volume":"76","author":"Chen","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.jacbts.2021.12.010_bib74","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.1073\/pnas.1215927110","article-title":"Olfactory receptor responding to gut microbiota-derived signals plays a role in renin secretion and blood pressure regulation","volume":"110","author":"Pluznick","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jacbts.2021.12.010_bib75","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1161\/CIRCRESAHA.116.309006","article-title":"Hypertension-linked pathophysiological alterations in the gut","volume":"120","author":"Santisteban","year":"2017","journal-title":"Circ Res"},{"key":"10.1016\/j.jacbts.2021.12.010_bib76","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1007\/s00424-019-02322-y","article-title":"Butyric acid, a gut bacteria metabolite, lowers arterial blood pressure via colon-vagus nerve signaling and GPR41\/43 receptors","volume":"471","author":"Onyszkiewicz","year":"2019","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.jacbts.2021.12.010_bib77","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1167\/iovs.11-8447","article-title":"GPR109A as an anti-inflammatory receptor in retinal pigment epithelial cells and its relevance to diabetic retinopathy","volume":"53","author":"Gambhir","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jacbts.2021.12.010_bib78","doi-asserted-by":"crossref","first-page":"983401","DOI":"10.1155\/2014\/983401","article-title":"BHBA suppresses LPS-induced inflammation in BV-2 cells by inhibiting NF-kappaB activation","volume":"2014","author":"Fu","year":"2014","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.jacbts.2021.12.010_bib79","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nm.3804","article-title":"The ketone metabolite beta-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease","volume":"21","author":"Youm","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.jacbts.2021.12.010_bib80","doi-asserted-by":"crossref","first-page":"66444","DOI":"10.18632\/oncotarget.12119","article-title":"\u03b2-Hydroxybutyrate suppresses inflammasome formation by ameliorating endoplasmic reticulum stress via AMPK activation","volume":"7","author":"Bae","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jacbts.2021.12.010_bib81","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1161\/CIRCRESAHA.120.317933","article-title":"Targeting mitochondria-inflammation circuit by \u03b2-hydroxybutyrate mitigates HFpEF","volume":"128","author":"Deng","year":"2021","journal-title":"Circ Res"},{"key":"10.1016\/j.jacbts.2021.12.010_bib82","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1038\/s41467-018-05901-2","article-title":"Microbiota-derived short-chain fatty acids promote Th1 cell IL-10 production to maintain intestinal homeostasis","volume":"9","author":"Sun","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.jacbts.2021.12.010_bib83","doi-asserted-by":"crossref","first-page":"6734","DOI":"10.1038\/ncomms7734","article-title":"Metabolite-sensing receptors GPR43 and GPR109A facilitate dietary fibre-induced gut homeostasis through regulation of the inflammasome","volume":"6","author":"Macia","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.jacbts.2021.12.010_bib84","doi-asserted-by":"crossref","first-page":"16148","DOI":"10.1038\/srep16148","article-title":"The effect of short-chain fatty acids on human monocyte-derived dendritic cells","volume":"5","author":"Nastasi","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.jacbts.2021.12.010_bib85","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1046\/j.0009-9104.2002.01977.x","article-title":"Butyrate affects differentiation, maturation and function of human monocyte-derived dendritic cells and macrophages","volume":"130","author":"Millard","year":"2002","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jacbts.2021.12.010_bib86","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.bbrc.2016.05.097","article-title":"\u03b2-Hydroxybutyrate elevation as a compensatory response against oxidative stress in cardiomyocytes","volume":"475","author":"Nagao","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jacbts.2021.12.010_bib87","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1093\/ndt\/gfr807","article-title":"Sodium butyrate decreases the activation of NF-kappaB reducing inflammation and oxidative damage in the kidney of rats subjected to contrast-induced nephropathy","volume":"27","author":"Machado","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jacbts.2021.12.010_bib88","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1055\/s-0042-121493","article-title":"Short-chain fatty acids inhibit oxidative stress and inflammation in mesangial cells induced by high glucose and lipopolysaccharide","volume":"125","author":"Huang","year":"2017","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.jacbts.2021.12.010_bib89","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jnutbio.2016.05.002","article-title":"Oral butyrate reduces oxidative stress in atherosclerotic lesion sites by a mechanism involving NADPH oxidase down-regulation in endothelial cells","volume":"34","author":"Aguilar","year":"2016","journal-title":"J\u00a0Nutr Biochem"},{"key":"10.1016\/j.jacbts.2021.12.010_bib90","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.freeradbiomed.2018.06.034","article-title":"Sodium butyrate attenuates diabetes-induced aortic endothelial dysfunction via P300-mediated transcriptional activation of Nrf2","volume":"124","author":"Wu","year":"2018","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.jacbts.2021.12.010_bib91","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.201900616","article-title":"Probiotics prevent dysbiosis and the rise in blood pressure in genetic hypertension: role of short-chain fatty acids","volume":"64","author":"Robles-Vera","year":"2020","journal-title":"Mol Nutr Food Res"},{"key":"10.1016\/j.jacbts.2021.12.010_bib92","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1161\/CIRCULATIONAHA.116.026807","article-title":"Evidence supporting the existence of a distinct obese phenotype of heart failure with preserved ejection fraction","volume":"136","author":"Obokata","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2021.12.010_bib93","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.115.002978","article-title":"Association of weight and body composition on cardiac structure and function in the ARIC study (Atherosclerosis Risk in Communities)","volume":"9","author":"Bello","year":"2016","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacbts.2021.12.010_bib94","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1056\/NEJMoa020245","article-title":"Obesity and the risk of heart failure","volume":"347","author":"Kenchaiah","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacbts.2021.12.010_bib95","first-page":"701","article-title":"The association of obesity and cardiometabolic traits with incident HFpEF and HFrEF","volume":"6","author":"Savji","year":"2018","journal-title":"J\u00a0Am Coll Cardiol HF"},{"key":"10.1016\/j.jacbts.2021.12.010_bib96","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1001\/jama.294.3.334","article-title":"Insulin resistance and risk of congestive heart failure","volume":"294","author":"Ingelsson","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.jacbts.2021.12.010_bib97","first-page":"531","article-title":"Insulin resistance and incident heart failure the ARIC study (Atherosclerosis Risk in Communities)","volume":"1","author":"Vardeny","year":"2013","journal-title":"J\u00a0Am Coll Cardiol HF"},{"key":"10.1016\/j.jacbts.2021.12.010_bib98","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1161\/CIRCHEARTFAILURE.112.972828","article-title":"Predictors of new-onset heart failure: differences in preserved versus reduced ejection fraction","volume":"6","author":"Ho","year":"2013","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacbts.2021.12.010_bib99","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12933-014-0168-x","article-title":"Diastolic dysfunction in the diabetic continuum: association with insulin resistance, metabolic syndrome and type 2 diabetes","volume":"14","author":"Fontes-Carvalho","year":"2015","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.jacbts.2021.12.010_bib100","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1113\/JP276747","article-title":"Cardiomyopathy in obesity, insulin resistance and diabetes","volume":"598","author":"Nakamura","year":"2020","journal-title":"J\u00a0Physiol"},{"key":"10.1016\/j.jacbts.2021.12.010_bib101","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/BF01219433","article-title":"Changes in the concentrations of glucose, free fatty acids, insulin and ketone bodies in the blood during sodium beta-hydroxybutyrate infusions in man","volume":"4","author":"Balasse","year":"1968","journal-title":"Diabetologia"},{"key":"10.1016\/j.jacbts.2021.12.010_bib102","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1210\/jc.2014-2608","article-title":"Systemic, cerebral and skeletal muscle ketone body and energy metabolism during acute hyper-D-beta-hydroxybutyratemia in post-absorptive healthy males","volume":"100","author":"Mikkelsen","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jacbts.2021.12.010_bib103","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.2337\/db14-1213","article-title":"Short-chain fatty acids protect against high-fat diet-induced obesity via a PPAR\u03b3-dependent switch from lipogenesis to fat oxidation","volume":"64","author":"den Besten","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.jacbts.2021.12.010_bib104","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.2337\/db08-1637","article-title":"Butyrate improves insulin sensitivity and increases energy expenditure in mice","volume":"58","author":"Gao","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.jacbts.2021.12.010_bib105","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacbts.2021.12.010_bib106","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1161\/CIRCULATIONAHA.118.035759","article-title":"Improvement in cardiovascular outcomes with empagliflozin is independent of glycemic control","volume":"138","author":"Inzucchi","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2021.12.010_bib107","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.2337\/db16-0733","article-title":"The sodium-glucose cotransporter 2 inhibitor dapagliflozin prevents cardiomyopathy in a diabetic lipodystrophic mouse model","volume":"66","author":"Joubert","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/j.jacbts.2021.12.010_bib108","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.freeradbiomed.2017.01.035","article-title":"Dapagliflozin, a selective SGLT2 inhibitor, attenuated cardiac fibrosis by regulating the macrophage polarization via STAT3 signaling in infarcted rat hearts","volume":"104","author":"Lee","year":"2017","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.jacbts.2021.12.010_bib109","doi-asserted-by":"crossref","first-page":"e212","DOI":"10.2337\/dc16-1312","article-title":"Effect of empagliflozin on left ventricular mass and diastolic function in individuals with diabetes: an important clue to the EMPA-REG OUTCOME trial?","volume":"39","author":"Verma","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacbts.2021.12.010_bib110","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.2337\/db15-1356","article-title":"Shift to fatty substrate utilization in response to sodium-glucose cotransporter 2 inhibition in subjects without diabetes and patients with type 2 diabetes","volume":"65","author":"Ferrannini","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.jacbts.2021.12.010_bib111","doi-asserted-by":"crossref","first-page":"758080","DOI":"10.3389\/fphar.2021.758080","article-title":"Sodium-glucose co-transporter 2 inhibition with empagliflozin improves cardiac function after cardiac arrest in rats by enhancing mitochondrial energy metabolism","volume":"12","author":"Tan","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jacbts.2021.12.010_bib112","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/s12933-021-01410-7","article-title":"Effect of empagliflozin on ketone bodies in patients with stable chronic heart failure","volume":"20","author":"Pietschner","year":"2021","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.jacbts.2021.12.010_bib113","first-page":"575","article-title":"Empagliflozin increases cardiac energy production in diabetes: novel translational insights into the heart failure benefits of SGLT2 inhibitors","volume":"3","author":"Verma","year":"2018","journal-title":"J\u00a0Am Coll Cardiol Basic Trans Science"},{"key":"10.1016\/j.jacbts.2021.12.010_bib114","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/dom.13536","article-title":"Empagliflozin reduces myocardial ketone utilization while preserving glucose utilization in diabetic hypertensive heart disease: a hyperpolarized 13C magnetic resonance spectroscopy study","volume":"21","author":"Abdurrachim","year":"2019","journal-title":"Diabetes Obes Metab"},{"issue":"suppl 27","key":"10.1016\/j.jacbts.2021.12.010_bib115","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/pedi.12701","article-title":"ISPAD clinical practice consensus guidelines 2018: diabetic ketoacidosis and the hyperglycemic hyperosmolar state","volume":"19","author":"Wolfsdorf","year":"2018","journal-title":"Pediatr Diabetes"},{"issue":"5","key":"10.1016\/j.jacbts.2021.12.010_bib116","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.2886","article-title":"Ketosis and diabetic ketoacidosis in response to SGLT2 inhibitors: basic mechanisms and therapeutic perspectives","volume":"33","author":"Qiu","year":"2017","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.jacbts.2021.12.010_bib117","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1001\/archinte.166.3.285","article-title":"Effects of low-carbohydrate vs low-fat diets on weight loss and cardiovascular risk factors: a meta-analysis of randomized controlled trials","volume":"166","author":"Nordmann","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacbts.2021.12.010_bib118","doi-asserted-by":"crossref","first-page":"748","DOI":"10.3945\/ajcn.110.002758","article-title":"A\u00a0high-fat diet impairs cardiac high-energy phosphate metabolism and cognitive function in healthy human subjects","volume":"93","author":"Holloway","year":"2011","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jacbts.2021.12.010_bib119","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jacl.2020.10.005","article-title":"Ketogenic diets, not for everyone","volume":"15","author":"Goldberg","year":"2021","journal-title":"J\u00a0Clin Lipidol"},{"key":"10.1016\/j.jacbts.2021.12.010_bib120","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1123\/ijsnem.2018-0284","article-title":"The effect of 1,3-butanediol on cycling time-trial performance","volume":"29","author":"Shaw","year":"2019","journal-title":"Int J Sport Nutr Exerc Metab"}],"container-title":["JACC: Basic to Translational Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452302X22000043?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452302X22000043?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:25:14Z","timestamp":1762820714000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452302X22000043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":120,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S2452302X22000043"],"URL":"https:\/\/doi.org\/10.1016\/j.jacbts.2021.12.010","relation":{},"ISSN":["2452-302X"],"issn-type":[{"value":"2452-302X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Short-Chain Carbon Sources","name":"articletitle","label":"Article Title"},{"value":"JACC: Basic to Translational Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacbts.2021.12.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}]}}